| Norovirus VLPs and rotavirus VP6 protein as combined vaccine for childhood gastroenteritis V Blazevic, S Lappalainen, K Nurminen, L Huhti, T Vesikari Vaccine 29 (45), 8126-8133, 2011 | 141 | 2011 |
| Primary Cutaneous T-Cell Lymphomas Show a Deletion or Translocation Affecting NAV3, the Human UNC-53 Homologue L Karenko, S Hahtola, S Päivinen, R Karhu, S Syrjä, M Kähkönen, ... Cancer research 65 (18), 8101-8110, 2005 | 121 | 2005 |
| Trivalent combination vaccine induces broad heterologous immune responses to norovirus and rotavirus in mice K Tamminen, S Lappalainen, L Huhti, T Vesikari, V Blazevic PloS one 8 (7), e70409, 2013 | 105 | 2013 |
| A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles L Huhti, V Blazevic, K Nurminen, T Koho, VP Hytönen, T Vesikari Archives of virology 155, 1855-1858, 2010 | 105 | 2010 |
| Prevalence of norovirus GII‐4 antibodies in Finnish children K Nurminen, V Blazevic, L Huhti, S Räsänen, T Koho, VP Hytönen, ... Journal of medical virology 83 (3), 525-531, 2011 | 97 | 2011 |
| A comparison of immunogenicity of norovirus GII‐4 virus‐like particles and P‐particles K Tamminen, L Huhti, T Koho, S Lappalainen, VP Hytönen, T Vesikari, ... Immunology 135 (1), 89-99, 2012 | 93 | 2012 |
| High serum levels of norovirus genotype–specific blocking antibodies correlate with protection from infection in children M Malm, H Uusi-Kerttula, T Vesikari, V Blazevic The Journal of infectious diseases 210 (11), 1755-1762, 2014 | 87 | 2014 |
| Norovirus GII-4 causes a more severe gastroenteritis than other noroviruses in young children L Huhti, ED Szakal, L Puustinen, M Salminen, H Huhtala, O Valve, ... Journal of Infectious Diseases 203 (10), 1442-1444, 2011 | 83 | 2011 |
| Noroviruses as a major cause of acute gastroenteritis in children in Finland, 2009–2010 L Puustinen, V Blazevic, M Salminen, M Hämäläinen, S Räsänen, ... Scandinavian journal of infectious diseases 43 (10), 804-808, 2011 | 76 | 2011 |
| Norovirus genotypes in endemic acute gastroenteritis of infants and children in Finland between 1994 and 2007 L Puustinen, V Blazevic, L Huhti, ED Szakal, A Halkosalo, M Salminen, ... Epidemiology & Infection 140 (2), 268-275, 2012 | 66 | 2012 |
| His-tagged norovirus-like particles: A versatile platform for cellular delivery and surface display T Koho, TO Ihalainen, M Stark, H Uusi-Kerttula, R Wieneke, R Rahikainen, ... European Journal of Pharmaceutics and Biopharmaceutics 96, 22-31, 2015 | 57 | 2015 |
| Protection against live rotavirus challenge in mice induced by parenteral and mucosal delivery of VP6 subunit rotavirus vaccine S Lappalainen, AR Pastor, M Malm, V López-Guerrero, ... Archives of virology 160, 2075-2078, 2015 | 57 | 2015 |
| Production and characterization of virus-like particles and the P domain protein of GII. 4 norovirus T Koho, L Huhti, V Blazevic, K Nurminen, SJ Butcher, P Laurinmäki, ... Journal of virological methods 179 (1), 1-7, 2012 | 57 | 2012 |
| Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo S Lappalainen, AR Pastor, K Tamminen, V López-Guerrero, ... Human vaccines & immunotherapeutics 10 (7), 2039-2047, 2014 | 55 | 2014 |
| Inhibition of human immunodeficiency virus type 1 replication prior to reverse transcription by influenza virus stimulation LA Pinto, V Blazevic, BK Patterson, C Mac Trubey, MJ Dolan, GM Shearer Journal of virology 74 (10), 4505-4511, 2000 | 49 | 2000 |
| Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles S Lappalainen, K Tamminen, T Vesikari, V Blazevic Human vaccines & immunotherapeutics 9 (9), 1991-2001, 2013 | 43 | 2013 |
| Cross-clade protection induced by human immunodeficiency virus-1 DNA immunogens expressing consensus sequences of multiple genes and epitopes from subtypes A, B, C, and FGH M Malm, E Rollman, M Ustav, J Hinkula, K Krohn, B Wahren, V Blazevic Viral immunology 18 (4), 678-688, 2005 | 41 | 2005 |
| Comparison of human saliva and synthetic histo-blood group antigens usage as ligands in norovirus-like particle binding and blocking assays H Uusi-Kerttula, K Tamminen, M Malm, T Vesikari, V Blazevic Microbes and Infection 16 (6), 472-480, 2014 | 38 | 2014 |
| Rapid and sensitive detection of norovirus antibodies in human serum with a biolayer interferometry biosensor S Auer, T Koho, H Uusi-Kerttula, T Vesikari, V Blazevic, VP Hytönen Sensors and Actuators B: Chemical 221, 507-514, 2015 | 37 | 2015 |
| Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine V Blazevic, M Malm, D Arinobu, S Lappalainen, T Vesikari Human vaccines & immunotherapeutics 12 (3), 740-748, 2016 | 36 | 2016 |
